Anlotinib Enhances the Antitumor Activity of High-Dose Irradiation Combined with Anti-PD-L1 by Potentiating the Tumor Immune Microenvironment in Murine Lung Cancer

<div>Levels of cell cytokines associated with the activity and function of immune cells. CTRL: control; RT: radiotherapy; IO: immunotherapy; AN: anlotinib.</div>

Oxidative Medicine and Cellular Longevity

fig5

Figure 5

Figure 5: Anlotinib Enhances the Antitumor Activity of High-Dose Irradiation Combined with Anti-PD-L1 by Potentiating the Tumor Immune Microenvironment in Murine Lung Cancer 

Figure 5 | Anlotinib Enhances the Antitumor Activity of High-Dose Irradiation Combined with Anti-PD-L1 by Potentiating the Tumor Immune Microenvironment in Murine Lung Cancer 